skip to main content
Back to Top

Funding Opportunities

NIH Safety and Outcome Measures of Pain Medications used in Children and Pregnant Women (R01, R03, R21)

by Nicole Gervais | Jun 20, 2017

The purpose of this funding opportunity announcement (FOA) is to (1) promote preclinical, translational, clinical and epidemiological research in pain medications use in children or in pregnant women to fill knowledge gaps in safe use of the pain medications in these special populations; and (2) develop effective instruments or approaches to assess and evaluate maternal and child outcomes of pain medication treatments.

There is a need for data on pain medications used in children and pregnant women to be shared and made available to the scientific community for future studies and to encourage replication of findings and meeting the goal of further advancing research in this area.

R01 - Research Grant - no fixed budget, 1-5 years Due: Feb 5, June 5, Oct 5
R03 - Small Project Grant - $100,000 over 2 years.  Due: Feb 16, June 16, Oct 16
R21 - Exploratory/Developmental Research Grant - $275,000 over 2 years.  Due Feb 16, June 16, Oct 16

Click here for more information


© 201​6 McMaster University  |  1280 Main Street West  |  Hamilton, Ontario ​L8S 4K1  |  905-521-2100   |  Contact Us | Terms of Use & Privacy Policy